Nitroglycerin is a potent organic nitrate vasodilator, primarily used for the prophylaxis and treatment of angina pectoris. It acts by relaxing vascular smooth muscle, leading to venous and arterial dilation. This reduces myocardial oxygen demand (by decreasing preload and afterload) and improves oxygen supply (by dilating coronary arteries). The 2.5mg strength is typically formulated as a sublingual tablet for rapid relief of acute anginal attacks.
Adult: For acute angina: 2.5mg tablet placed under the tongue at the first sign of an attack. Dose may be repeated every 5 minutes if pain persists, up to a maximum of 3 tablets in 15 minutes. For prophylaxis: 2.5mg sublingually 5-10 minutes before anticipated physical or emotional stress.
Note: Patient should be SITTING DOWN when taking the first dose. Place tablet under the tongue and allow it to dissolve completely. Do not chew, crush, or swallow. Avoid eating, drinking, or smoking until tablet dissolves. If pain is not relieved after 3 doses in 15 minutes, seek emergency medical attention immediately.
Nitroglycerin is converted to nitric oxide (NO) within vascular smooth muscle cells, primarily by mitochondrial aldehyde dehydrogenase (ALDH2) in veins and arteries. NO activates soluble guanylyl cyclase, increasing intracellular cyclic guanosine monophosphate (cGMP). Elevated cGMP leads to dephosphorylation of myosin light chains, resulting in smooth muscle relaxation and vasodilation.
Pregnancy: Category C (US FDA). Animal studies show adverse effects. Use only if potential benefit justifies potential risk to the fetus. Avoid during labor and delivery as it may interfere with uterine contractility.
Driving: May cause dizziness, lightheadedness, or syncope, especially after the first dose. Patients should not drive or operate machinery until they know how the drug affects them.
| Phosphodiesterase-5 Inhibitors (Sildenafil, Tadalafil, Vardenafil) | Profound, life-threatening hypotension | Contraindicated |
| Other Vasodilators (ACE inhibitors, ARBs, Calcium channel blockers, Alpha-blockers) | Additive hypotensive effect | Major |
| Alcohol | Enhanced vasodilation and hypotension | Major |
| Heparin | Nitroglycerin may decrease anticoagulant effect of heparin | Moderate |
| Dihydroergotamine | Nitroglycerin may increase ergotamine bioavailability, increasing vasoconstrictive effects | Moderate |
| Antihypertensives | Additive blood pressure lowering | Moderate |
| Tricyclic Antidepressants (TCAs) | May exacerbate hypotension | Moderate |
Same composition (Nitroglycerin (2.5mg)), different brands: